These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Metabolic aspects of obesity]. Doar JW Minerva Med; 1968 Apr; 59(30):1786-90. PubMed ID: 5653953 [No Abstract] [Full Text] [Related]
7. [Drugs and obesity: current status, prospects for the future]. Apfelbaum M Rev Prat; 1984 Dec; 34(55):3121-4. PubMed ID: 6505592 [No Abstract] [Full Text] [Related]
8. [Contribution to a study of a new lipolytic and anorectic drug: fenproporex (author's transl)]. Nájera Mortes J Folia Clin Int (Barc); 1973 Feb; 23(2):134-51. PubMed ID: 4804960 [No Abstract] [Full Text] [Related]
9. [Progress in the treatment of obesity]. Zahorska-Markiewicz B; Kucio C; Rudnicki M Pol Tyg Lek; 1987 May; 42(20):628-31. PubMed ID: 3313310 [No Abstract] [Full Text] [Related]
10. [Reducing diet and protein catabolism]. Dettwiler W; Wyss F Rev Med Suisse Romande; 1970 Jun; 90(6):479-94. PubMed ID: 5528073 [No Abstract] [Full Text] [Related]
11. [Differentiated indications in the treatment of obesity: current data]. Laurent-Jaccard A Schweiz Rundsch Med Prax; 1986 Jun; 75(23):706-9. PubMed ID: 3726368 [No Abstract] [Full Text] [Related]
19. [Clinical study of a current anorexigenic agent: T.D]. Plauchu M; Paffoy JC; Philippe LP; Nove-Josserand G; Chollet A; Valancogne C Lyon Med; 1972 Oct; 228(15):291-4. PubMed ID: 4639053 [No Abstract] [Full Text] [Related]
20. Obesity. Pathogenesis, consequences, and approaches to treatment. Weiss SR Psychiatr Clin North Am; 1984 Jun; 7(2):307-19. PubMed ID: 6473186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]